Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Silane fluoride + chlorhexidine is a combination oral antiseptic and anti-caries agent used primarily in dentistry to manage and prevent gingivitis, reduce dental plaque, and promote oral hygiene. Chlorhexidine is a broad-spectrum antimicrobial that disrupts microbial cell membranes, leading to cell death. Silane fluorides (such as quaternary ammonium silanes or other organosilicon fluorides) act as topical fluoride agents that help remineralize enamel and inhibit demineralization, thereby preventing dental caries. The combination leverages the antibacterial properties of chlorhexidine with the anti-caries effects of fluoride for enhanced protection against oral pathogens and tooth decay[2][7][10]. This formulation is typically supplied as a mouthwash or varnish for direct application in the oral cavity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on silane fluoride + chlorhexidine.